Jim Cramer says economic data can’t capture one huge driver of inflation

Jim Cramer says economic data can’t capture one huge driver of inflation


Jim Cramer says economic data can't capture one huge driver of inflation

CNBC’s Jim Cramer on Thursday said that a huge driver of inflation is the consumer’s desire to spend money in the reopening economy – a fact that isn’t reflected in the data that the Federal Reserve and Wall Street are poring over.

“They don’t care about higher rates. They have savings because they did nothing for two years,” he said. “My biggest worry right now is that the aggregate data can’t capture the nature of this … one-time-only euphoria.”

Stocks slumped on Thursday after a strong start to the week that fizzled out by Wednesday. Investors are eyeing the nonfarm payrolls report release on Friday to gauge the size of the Federal Reserve’s next interest rate hike. 

If job and wage growth is stronger than expected, the Fed is likely to stay the course on its aggressive campaign.

While a surge in travel this summer showed that Americans were eager to engage in revenge travel after Covid restrictions loosened, some are also now experiencing “recession fatigue” – waning motivation to continue making smart financial choices to prepare for tough economic times ahead.

Cramer noted that he expects consumers’ need to spend to wind down eventually, though it might not happen anytime soon.

“A year from now, there probably will be no euphoria. It’ll be over. They’ll have spent their excess savings. And that’s exactly when interest rates will likely be at their max,” Cramer said.

Jim Cramer on the 'euphoria' driving inflation higher

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More